nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—HLA-C—malignant glioma	0.0437	0.0439	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—PML—malignant glioma	0.0437	0.0439	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—HLA-C—malignant glioma	0.0389	0.039	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PIK3CB—malignant glioma	0.0349	0.035	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Regulation of actin dynamics for phagocytic cup formation—PTK2—malignant glioma	0.0324	0.0326	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—HLA-B—malignant glioma	0.0259	0.026	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PTK2—malignant glioma	0.0245	0.0246	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—HLA-A—malignant glioma	0.024	0.0241	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL7—malignant glioma	0.0237	0.0238	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—HLA-B—malignant glioma	0.023	0.0231	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—HLA-C—malignant glioma	0.0214	0.0214	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—PML—malignant glioma	0.0214	0.0214	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Antigen processing-Cross presentation—HLA-A—malignant glioma	0.0213	0.0214	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Role of phospholipids in phagocytosis—PIK3CA—malignant glioma	0.0213	0.0213	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—PTPN11—malignant glioma	0.0198	0.0199	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—PARK2—malignant glioma	0.0173	0.0173	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon gamma signaling—IFNG—malignant glioma	0.016	0.016	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNA2—malignant glioma	0.0156	0.0157	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—HLA-C—malignant glioma	0.0155	0.0156	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HLA-C—malignant glioma	0.0143	0.0143	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PML—malignant glioma	0.0143	0.0143	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CB—malignant glioma	0.0136	0.0137	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—FBXW7—malignant glioma	0.013	0.013	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—HLA-B—malignant glioma	0.0126	0.0127	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—HLA-A—malignant glioma	0.0117	0.0117	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CFH—malignant glioma	0.0117	0.0117	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNA2—malignant glioma	0.0104	0.0105	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—PTPN11—malignant glioma	0.00969	0.00972	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—HLA-B—malignant glioma	0.00918	0.00921	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—LGALS3—malignant glioma	0.0089	0.00893	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PARK2—malignant glioma	0.00855	0.00858	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Class I MHC mediated antigen processing & presentation—HLA-A—malignant glioma	0.0085	0.00853	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HLA-B—malignant glioma	0.00844	0.00846	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Fcgamma receptor (FCGR) dependent phagocytosis—PIK3CA—malignant glioma	0.0083	0.00833	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HLA-C—malignant glioma	0.008	0.00803	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—HLA-A—malignant glioma	0.00782	0.00784	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Interferon Signaling—IFNG—malignant glioma	0.00781	0.00784	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL7—malignant glioma	0.00774	0.00777	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-C—malignant glioma	0.00768	0.00771	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CTSB—malignant glioma	0.00743	0.00745	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CTSB—malignant glioma	0.00713	0.00716	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—DUSP6—malignant glioma	0.00692	0.00694	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CFH—malignant glioma	0.00679	0.00681	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PTPN11—malignant glioma	0.00647	0.00649	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FBXW7—malignant glioma	0.00643	0.00645	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—IFNA2—malignant glioma	0.00585	0.00587	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CD—malignant glioma	0.00579	0.00581	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IFNG—malignant glioma	0.00522	0.00523	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PARK2—malignant glioma	0.00518	0.0052	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—LGALS3—malignant glioma	0.00518	0.0052	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—RAF1—malignant glioma	0.00517	0.00519	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PTK2—malignant glioma	0.00509	0.00511	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CB—malignant glioma	0.00505	0.00506	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PDGFRA—malignant glioma	0.00476	0.00478	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—HLA-B—malignant glioma	0.00473	0.00475	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-C—malignant glioma	0.00466	0.00468	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PML—malignant glioma	0.00466	0.00468	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL1B—malignant glioma	0.00465	0.00467	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—IL2—malignant glioma	0.00463	0.00465	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PDGFRA—malignant glioma	0.00457	0.00459	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-B—malignant glioma	0.00454	0.00456	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CTSB—malignant glioma	0.00433	0.00434	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PDGFB—malignant glioma	0.00428	0.00429	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGFR1—malignant glioma	0.00426	0.00427	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—HLA-A—malignant glioma	0.00421	0.00422	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PDGFB—malignant glioma	0.00411	0.00412	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGFR1—malignant glioma	0.00409	0.0041	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—DUSP6—malignant glioma	0.00403	0.00404	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—STAT3—malignant glioma	0.0039	0.00391	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FBXW7—malignant glioma	0.0039	0.00391	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BAD—malignant glioma	0.00381	0.00383	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—CD80—malignant glioma	0.0037	0.00371	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—BAD—malignant glioma	0.00366	0.00367	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—EGF—malignant glioma	0.00365	0.00366	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PTPN11—malignant glioma	0.00363	0.00364	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—CD80—malignant glioma	0.00355	0.00356	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—EGF—malignant glioma	0.00351	0.00352	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PTPN11—malignant glioma	0.00348	0.0035	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IFNA2—malignant glioma	0.00341	0.00342	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—AKT2—malignant glioma	0.00338	0.00339	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—KRAS—malignant glioma	0.00335	0.00336	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CD—malignant glioma	0.00325	0.00326	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—AKT2—malignant glioma	0.00324	0.00326	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CD—malignant glioma	0.00312	0.00313	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—FGF2—malignant glioma	0.00311	0.00312	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Cytokine Signaling in Immune system—PIK3CA—malignant glioma	0.00308	0.00309	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—FGF2—malignant glioma	0.00298	0.003	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PTK2—malignant glioma	0.00297	0.00298	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—BCL2—malignant glioma	0.00295	0.00296	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—MDM2—malignant glioma	0.00291	0.00292	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—RAF1—malignant glioma	0.0029	0.00291	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—ERBB2—malignant glioma	0.00287	0.00288	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CB—malignant glioma	0.00283	0.00284	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—MDM2—malignant glioma	0.00279	0.0028	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—RAF1—malignant glioma	0.00278	0.00279	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PDGFRA—malignant glioma	0.00277	0.00278	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-B—malignant glioma	0.00276	0.00276	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—ERBB2—malignant glioma	0.00275	0.00276	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CB—malignant glioma	0.00272	0.00273	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—HLA-A—malignant glioma	0.00255	0.00256	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PDGFB—malignant glioma	0.00249	0.0025	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FGFR1—malignant glioma	0.00248	0.00249	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PTEN—malignant glioma	0.00245	0.00245	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PTEN—malignant glioma	0.00235	0.00236	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BAD—malignant glioma	0.00222	0.00223	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—CD80—malignant glioma	0.00215	0.00216	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—EGF—malignant glioma	0.00213	0.00213	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PTPN11—malignant glioma	0.00211	0.00212	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—EGFR—malignant glioma	0.00199	0.00199	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AKT2—malignant glioma	0.00197	0.00197	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—EGFR—malignant glioma	0.00191	0.00192	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CD—malignant glioma	0.00189	0.0019	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—KRAS—malignant glioma	0.00188	0.00188	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—FGF2—malignant glioma	0.00181	0.00182	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—KRAS—malignant glioma	0.0018	0.00181	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—PIK3CA—malignant glioma	0.00173	0.00173	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—BCL2—malignant glioma	0.00172	0.00173	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IFNG—malignant glioma	0.0017	0.00171	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—MDM2—malignant glioma	0.00169	0.0017	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—RAF1—malignant glioma	0.00169	0.00169	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—ERBB2—malignant glioma	0.00167	0.00168	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—PIK3CA—malignant glioma	0.00166	0.00166	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CB—malignant glioma	0.00165	0.00165	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL1B—malignant glioma	0.00152	0.00152	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—IL2—malignant glioma	0.00151	0.00152	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PTEN—malignant glioma	0.00142	0.00143	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Innate Immune System—AKT1—malignant glioma	0.00141	0.00141	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Adaptive Immune System—AKT1—malignant glioma	0.00135	0.00136	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—STAT3—malignant glioma	0.00127	0.00128	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—EGFR—malignant glioma	0.00116	0.00116	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—KRAS—malignant glioma	0.00109	0.0011	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—PIK3CA—malignant glioma	0.001	0.00101	CbGpPWpGaD
Methyl aminolevulinate—FCGR1A—Immune System—AKT1—malignant glioma	0.000821	0.000824	CbGpPWpGaD
Methyl aminolevulinate—Skin hyperpigmentation—Carmustine—malignant glioma	0.000317	0.0927	CcSEcCtD
Methyl aminolevulinate—Burning sensation—Carmustine—malignant glioma	0.000271	0.0794	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Carmustine—malignant glioma	0.00018	0.0526	CcSEcCtD
Methyl aminolevulinate—Skin exfoliation—Temozolomide—malignant glioma	0.000174	0.0509	CcSEcCtD
Methyl aminolevulinate—Swelling—Carmustine—malignant glioma	0.000155	0.0454	CcSEcCtD
Methyl aminolevulinate—Eye pain—Carmustine—malignant glioma	0.000151	0.0443	CcSEcCtD
Methyl aminolevulinate—Eye pain—Temozolomide—malignant glioma	0.000146	0.0428	CcSEcCtD
Methyl aminolevulinate—Face oedema—Carmustine—malignant glioma	0.000132	0.0386	CcSEcCtD
Methyl aminolevulinate—Face oedema—Temozolomide—malignant glioma	0.000128	0.0373	CcSEcCtD
Methyl aminolevulinate—Photosensitivity reaction—Temozolomide—malignant glioma	0.000104	0.0305	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Carmustine—malignant glioma	8.84e-05	0.0259	CcSEcCtD
Methyl aminolevulinate—Eye disorder—Temozolomide—malignant glioma	8.54e-05	0.025	CcSEcCtD
Methyl aminolevulinate—Erythema—Carmustine—malignant glioma	8.23e-05	0.0241	CcSEcCtD
Methyl aminolevulinate—Erythema—Temozolomide—malignant glioma	7.95e-05	0.0233	CcSEcCtD
Methyl aminolevulinate—Oedema—Carmustine—malignant glioma	6.72e-05	0.0197	CcSEcCtD
Methyl aminolevulinate—Discomfort—Temozolomide—malignant glioma	6.69e-05	0.0196	CcSEcCtD
Methyl aminolevulinate—Infection—Carmustine—malignant glioma	6.67e-05	0.0195	CcSEcCtD
Methyl aminolevulinate—Oedema—Temozolomide—malignant glioma	6.49e-05	0.019	CcSEcCtD
Methyl aminolevulinate—Infection—Temozolomide—malignant glioma	6.45e-05	0.0189	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Carmustine—malignant glioma	6.03e-05	0.0177	CcSEcCtD
Methyl aminolevulinate—Paraesthesia—Temozolomide—malignant glioma	5.83e-05	0.0171	CcSEcCtD
Methyl aminolevulinate—Pain—Carmustine—malignant glioma	5.74e-05	0.0168	CcSEcCtD
Methyl aminolevulinate—Fatigue—Temozolomide—malignant glioma	5.6e-05	0.0164	CcSEcCtD
Methyl aminolevulinate—Pain—Temozolomide—malignant glioma	5.55e-05	0.0163	CcSEcCtD
Methyl aminolevulinate—Urticaria—Temozolomide—malignant glioma	5.16e-05	0.0151	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Carmustine—malignant glioma	4.95e-05	0.0145	CcSEcCtD
Methyl aminolevulinate—Asthenia—Carmustine—malignant glioma	4.82e-05	0.0141	CcSEcCtD
Methyl aminolevulinate—Hypersensitivity—Temozolomide—malignant glioma	4.78e-05	0.014	CcSEcCtD
Methyl aminolevulinate—Asthenia—Temozolomide—malignant glioma	4.66e-05	0.0136	CcSEcCtD
Methyl aminolevulinate—Pruritus—Temozolomide—malignant glioma	4.59e-05	0.0134	CcSEcCtD
Methyl aminolevulinate—Dizziness—Carmustine—malignant glioma	4.44e-05	0.013	CcSEcCtD
Methyl aminolevulinate—Dizziness—Temozolomide—malignant glioma	4.29e-05	0.0126	CcSEcCtD
Methyl aminolevulinate—Rash—Carmustine—malignant glioma	4.24e-05	0.0124	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Carmustine—malignant glioma	4.23e-05	0.0124	CcSEcCtD
Methyl aminolevulinate—Headache—Carmustine—malignant glioma	4.21e-05	0.0123	CcSEcCtD
Methyl aminolevulinate—Rash—Temozolomide—malignant glioma	4.09e-05	0.012	CcSEcCtD
Methyl aminolevulinate—Dermatitis—Temozolomide—malignant glioma	4.09e-05	0.012	CcSEcCtD
Methyl aminolevulinate—Headache—Temozolomide—malignant glioma	4.07e-05	0.0119	CcSEcCtD
Methyl aminolevulinate—Nausea—Carmustine—malignant glioma	3.99e-05	0.0117	CcSEcCtD
Methyl aminolevulinate—Nausea—Temozolomide—malignant glioma	3.86e-05	0.0113	CcSEcCtD
